₨ Official DRAP price
PKR 154.41
1’s
PKR 154.41 / vial/unit
✓ DRAP listed · Verified 2026-08-08
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 154.41/ vial/unit
Price positionNear medianvs like-for-like peer median
Peer comparators71current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Cefotaxime
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- —
- Strength
- 500 mg
- Dosage form
- Injection
- Pack
- 1’s
- Registration no.
- 054063
- Verification
- 2026-08-08
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 154.41 | 2024-07-01 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
ADOXIME cefotaxamine 500 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 151.49ADOXIME cefotaxamine 250 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 100.49ADOXIME cefotaxamine 1 gAdamjee Pharmaceuticals (Pvt) Ltd · PKR 272.42Algixim 500 mgEpharm Laboratories · PKR 168.48Algixim 1 gEpharm Laboratories · PKR 297.32Algixim 250 mgEpharm Laboratories · PKR 97.08Amzax 500 mgAMROS PHARMACEUTICALS · PKR 151.46Amzax 1 gAMROS PHARMACEUTICALS · PKR 272.43
Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.